News Author: Sharon Worcester Publish date: February 8, 2021
The Food and Drug Administration has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (C...
News Author: Sharon Worcester Publish date: February 4, 2021
Tepotinib is the first once-daily oral MET inhibitor approved for this patient population.
Article Author: Sharon Worcester Publish date: February 1, 2021
Recommended timing of vaccination varies based on cancer and treatment type.
News Author: Sharon Worcester Publish date: December 17, 2020
Breast cancer is now the most commonly diagnosed cancer worldwide, but lung cancer remains the leading overall ca...
News Author: Sharon Worcester Publish date: December 11, 2020
Higher rates of obesity and comorbidities in Black women with early breast cancer may explain the differences in ...
News Author: Sharon Worcester Publish date: December 4, 2020
Risk scores can identify patients at high risk for VTE, and treatments that are effective and associated with low...
News Author: Sharon Worcester Publish date: November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News Author: Sharon Worcester Publish date: November 17, 2020
“Another very exciting development is that these immunotherapies are now demonstrating efficacy and increased tolerability over chemotherapy in the...
News Author: Sharon Worcester Publish date: November 10, 2020
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and long...
News Author: Sharon Worcester Publish date: October 28, 2020
The CAR T data are encouraging, but high-dose therapy and stem cell rescue may be just as good in chemosensitive ...
News Author: Sharon Worcester Publish date: October 23, 2020
“Overall, these data support the use of acalabrutinib in patients with relapsed/refractory CLL, including patient...
News Author: Sharon Worcester Publish date: October 21, 2020
Women at high risk of developing ovarian cancer want to have options when it comes to taking steps such as surger...
News Author: Sharon Worcester Publish date: September 30, 2020
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.
News Author: Sharon Worcester Publish date: September 18, 2020
“I think it’s an important message that the [cardiovascular event] risk is there, at about the same rate, in the second 5 years.”
News Author: Sharon Worcester Publish date: September 17, 2020
“It is important that we have new therapeutic options to be able to help these patients who are going to be in ne...